Gilead Trades at 13x. AbbVie Just Raised Guidance Again. One Is Priced Wrong.
Two biopharma giants sitting at opposite ends of the market’s attention span.
T-Mobile vs. AT&T. Both Report July 22. One Is the Better Buy.
Same earnings window, same sector, very different bets.
SK Hynix’s Roadshow Starts Today. The Clock Is Already Running.
The largest ADR listing in history prices this week, and most investors have no idea what they’re about to gain access to.
CEG Is Down 40% From Its High. It Reports July 30.
The largest nuclear operator in the US just signed Walmart. The stock is near a 52-week low.
Nike Is Down 45% From Its Peak. The Brand Is Still There.
The turnaround is real but slow. China is the problem nobody has solved yet.
Cheniere Trades 18% Below Its 52-Week High. Q2 Reports July 30.
Record LNG exports, a $500 million guidance hike, and a $10 billion buyback nobody is fully pricing.
META Reports July 29. The Stock Is Down About 29% and Is Plotting a Cloud Business Nobody Expected.
A $125B-$145B capex bet is either the worst trade in tech or the birth of the next AWS.
Uranium’s Supply Cliff Is Arriving on Schedule. Investors Are Still Looking the Wrong Way.
The world’s largest uranium producer just cut output. The demand side has never been stronger.
Micron Just Had the Best Quarter in Its History. The Stock Is Down.
Record earnings, sold-out supply, and a $25 billion capex ramp — yet the market is selling the news.
The $700 Billion Question Nobody Can Answer
Big Tech is spending more than ever on AI. The cash is almost gone.